Key Insights

Highlights

Treatment Research

5 treatments under study, led by 04 Lugols Solution

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03180970Phase 4Unknown

Different Lugol's Solution Concentration for Image Quality of Esophageal Lesions in Chromoendoscopy With Iodine Staining

Showing all 1 trials

Research Network

Common Treatments

  • 04 Lugols Solution1
  • 10 Lugols Solution1
  • 12 Lugols Solution1
  • 06 Lugols Solution1
  • 08 Lugols Solution1

Active Sponsors

  • Shandong University1

Top Investigators

Related Conditions

  • Image Quality Of Early Esophageal Squamous Neoplasia1

Activity Timeline